V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260018144 | 260009789 | 1.64 | 51.4 | Not known (9) | 2017-04-14 | 2017-06-30 | CHOP - 21 days | N | N | 260029603 | CHOP |
| 260018145 | 260009796 | 1.7 | 54.3 | Neo-adjuvant (N) | 2018-01-26 | 2018-02-04 | NIVOLUMAB | 2 | N | 260029622 | BENDAMUSTINE + OBINUTUZUMAB |
| 260018146 | 260009803 | 1.64 | null | Curative (C) | 2013-04-28 | 2013-07-28 | TRASTUZUMAB | N | N | 260029646 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260018147 | 260014661 | 1.64 | 103 | Curative (C) | 2016-05-01 | 2016-05-30 | CARBOPLATIN + ETOPOSIDE | N | N | 260029660 | CARBOPLATIN + ETOPOSIDE |
| 260018148 | 260009810 | null | 71.3 | null | 2016-06-26 | 2016-12-22 | BLEOMYCIN | N | N | 260029663 | BLEOMYCIN |
| 260018149 | 260009812 | 1.83 | 74 | Adjuvant (A) | 2016-10-19 | 2016-10-20 | BLEOMYCIN + VINCRISTINE | 02 | Y | 260029667 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260018150 | 260009814 | 1.75 | 102.5 | Curative (C) | 2014-12-16 | 2014-12-27 | Methotrexate High Dose (3g/m2) | 02 | N | 260029688 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260018151 | 260009815 | 1.72 | null | Palliative (P) | 2017-10-26 | 2017-12-15 | EP | N | null | 260029691 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260018152 | 260009820 | 1.65 | 83.5 | Palliative (P) | 2015-08-02 | 2015-08-02 | IPO | 02 | N | 260029695 | CARBOPLATIN + THIOTEPA + TOPOTECAN |
| 260018153 | 260009821 | 1.78 | 91 | Neo-adjuvant (N) | 2018-06-28 | 2018-06-28 | BOP | 2 | N | 260029697 | VIP |
| 260018154 | 260009824 | 1.78 | 73.6 | Curative (C) | 2018-03-07 | 2018-03-07 | Gemcitabine weekly | 2 | N | 260029713 | FBC |
| 260018155 | 260009826 | 1.75 | 138.2 | Palliative (P) | 2016-05-08 | 2016-05-29 | IFOSFAMIDE + PACLITAXEL | N | N | 260029719 | CARBOPLATIN + ETOPOSIDE |
| 260018156 | 260014672 | 1.63 | 82.4 | null | 2017-03-25 | 2017-03-25 | Carboplatin + Etoposide IV 3 day | N | N | 260029725 | GEMCITABINE + OXALIPLATIN |
| 260018157 | 260009831 | null | 58.3 | Curative (C) | 2017-08-29 | 2017-08-29 | Docetaxel + Trastuzumab (Maint) | N | N | 260029728 | DOCETAXEL + TRASTUZUMAB |
| 260018158 | 260017035 | null | 91.75 | Curative (C) | null | 2014-05-05 | PCV | Y | N | 260029746 | BLEOMYCIN |
| 260018159 | 260014675 | 1.8 | 102 | Palliative (P) | 2018-11-25 | 2018-11-25 | METHOTREXATE + VINCRISTINE | 02 | N | 260029754 | BLEOMYCIN |
| 260018160 | 260009844 | null | 47.3 | Disease modification (D) | null | 2018-09-15 | IVE | 2 | N | 260029821 | GEMCITABINE + OXALIPLATIN + PACLITAXEL |
| 260018161 | 260017040 | null | 55.6 | Curative (C) | null | 2018-04-23 | VIP | null | null | 260029823 | GEMCITABINE + OXALIPLATIN |
| 260018162 | 260014682 | 1.62 | 85 | Palliative (P) | 2015-08-05 | 2015-08-11 | BLEOMYCIN + VINCRISTINE | N | null | 260029834 | ICE |
| 260018163 | 260009852 | 1.78 | 79 | null | 2018-02-21 | 2018-04-18 | LIPOSOMAL DOXORUBICIN | N | N | 260029877 | DOCETAXEL + TRASTUZUMAB |
| 260018164 | 260009856 | 1.58 | 74.7 | Curative (C) | 2016-11-22 | 2016-12-04 | CVP | N | N | 260029894 | CHOP |
| 260018165 | 260018220 | 1.63 | 83 | Curative (C) | 2016-02-01 | 2017-10-25 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260029902 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260018166 | 260009863 | 1.75 | 87.8 | Curative (C) | 2016-11-01 | 2016-11-22 | BLEOMYCIN + VINCRISTINE | N | N | 260029958 | BLEOMYCIN |
| 260018167 | 260009866 | 1.69 | 96 | Curative (C) | 2018-02-15 | 2018-02-17 | STS Rhabdomyosarcoma RMS 2005 VA | 02 | N | 260029960 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260018168 | 260009872 | 1.77 | 96.7 | null | 2016-02-08 | 2016-02-15 | IVA | N | N | 260029988 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260018169 | 260009874 | 1.81 | 91.9 | null | 2014-10-30 | 2014-11-04 | IVADo | N | N | 260030000 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260018170 | 260009875 | null | 68 | Disease modification (D) | 2017-06-10 | 2017-06-12 | Docetaxel | N | null | 260030004 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260018171 | 260009879 | null | 83.6 | Palliative (P) | 2016-02-16 | 2016-03-15 | CARBO + THIOTEPA + TOPOTECAN | N | N | 260030019 | VINBLASTINE |
| 260018172 | 260014698 | 1.81 | 64.15 | Disease modification (D) | 2015-12-13 | 2015-12-25 | EP | N | N | 260030030 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260018173 | 260017050 | 1.84 | null | Palliative (P) | 2017-07-15 | 2017-08-05 | VIP | N | N | 260030041 | CARBOPLATIN + PACLITAXEL |
| 260018174 | 260009886 | 1.65 | 78.05 | Curative (C) | null | 2015-12-18 | Carboplatin + Etoposide IV 3 day | null | null | 260030042 | CARBOPLATIN + ETOPOSIDE |
| 260018175 | 260009889 | 1.54 | 65.4 | null | 2018-12-14 | 2018-12-14 | TRASTUZUMAB | 2 | N | 260030065 | BLEOMYCIN + VINCRISTINE |
| 260018176 | 260009891 | 1.83 | 81.4 | Disease modification (D) | 2019-02-14 | 2019-07-03 | Bortezomib + Cyclophos + Dex | 2 | N | 260030070 | LENALIDOMIDE |
| 260018178 | 260009896 | 1.78 | 81.5 | Curative (C) | 2017-08-09 | 2017-08-10 | POMB | 2 | N | 260030077 | PACLITAXEL |
| 260018179 | 260009902 | 1.75 | 85 | Curative (C) | null | 2015-06-01 | CYTARABINE + METHOTREXATE HD | 02 | N | 260030095 | CHLORAMBUCIL + RITUXIMAB |
| 260018180 | 260009907 | 1.7 | 85 | Adjuvant (A) | 2018-03-28 | 2018-03-29 | BLEOMYCIN | 02 | N | 260030119 | BLEOMYCIN |
| 260018181 | 260009910 | null | 81.5 | Adjuvant (A) | 2013-11-05 | 2014-05-20 | POMB | N | N | 260030125 | ACE (GERM CELL) |
| 260018183 | 260009915 | 1.64 | 62.9 | Neo-adjuvant (N) | 2016-05-17 | 2016-05-21 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | 2 | N | 260000643 | OBINUTUZUMAB |
| 260018184 | 260009925 | 1.7 | 64.4 | Curative (C) | 2018-11-28 | 2018-12-31 | CHOP - 21 days | N | N | 260006047 | CHOP |
| 260018185 | 260009927 | 1.85 | 76 | Curative (C) | 2017-11-29 | 2017-12-04 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260006875 | IFOSFAMIDE + PACLITAXEL |
| 260018186 | 260009937 | 1.72 | 87.4 | null | 2014-09-14 | 2015-11-15 | BLEOMYCIN | N | N | 260007261 | IFOSFAMIDE + PACLITAXEL |
| 260018187 | 260009944 | 1.57 | 72.6 | null | 2014-11-28 | 2015-02-21 | Cisplatin + Radiotherapy | N | N | 260007582 | LIPOSOMAL DOXORUBICIN |
| 260018188 | 260009948 | null | 67.9 | Curative (C) | 2018-11-20 | 2018-12-28 | GEMCITABINE + TIP | Y | N | 260007834 | CARBOPLATIN + PACLITAXEL |
| 260018189 | 260009949 | 1.63 | 74.5 | Palliative (P) | 2017-04-17 | 2017-04-22 | BLEOMYCIN + VINCRISTINE | 2 | N | 260007843 | CARBOPLATIN + PACLITAXEL |
| 260018190 | 260009952 | 1.5 | 93.7 | Palliative (P) | 2018-07-24 | 2018-07-26 | FEC 60 or 75 | 02 | N | 260007862 | NIVOLUMAB |
| 260018191 | 260009956 | 1.63 | null | Palliative (P) | 2018-05-01 | 2018-12-21 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | null | 260007889 | NIVOLUMAB |
| 260018192 | 260009959 | 1.81 | 60.4 | Curative (C) | 2015-09-16 | 2015-09-16 | CISPLATIN + IFOSFAMIDE + PACLITAXEL | 02 | N | 260007890 | IPO |
| 260018193 | 260009965 | null | 61 | Curative (C) | 2019-06-26 | 2019-06-27 | Carboplatin 21day + Paclitaxel 7day | 2 | N | 260007966 | TRASTUZUMAB |
| 260018194 | 260009976 | 1.67 | 67.6 | Adjuvant (A) | 2017-07-27 | 2017-12-09 | DOCETAXEL + TRASTUZUMAB | N | N | 260008307 | CISPLATIN + RT |
| 260018195 | 260009980 | 1.72 | 96 | Curative (C) | 2015-04-13 | 2015-04-19 | Panitumumab | N | N | 260008373 | EP |